Drug Research

Nektar Therapeutics announced that the U.S. Food and Drug Administration (FDA) has filed and accepted for review the company's New Drug Application (NDA) for NKTR-181 for the treatment…
Read More...

Eli Lilly and Company announced a three-year extension of its cancer research collaboration with Dana-Farber Cancer Institute. Since 2015, scientists from Lilly and Dana-Farber have…
Read More...

AstraZeneca and MedImmune, its global biologics research and development arm, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency…
Read More...

MilliporeSigma and InnoCore Pharmaceuticals; Groningen, Netherlands, have entered into a global cooperation agreement to provide InnoCore’s proprietary SynBiosys biodegradable polymer…
Read More...

AbbVie in cooperation with Neurocrine Biosciences announced that the U.S. Food and Drug Administration (FDA) approved ORILISSA™ (elagolix), the first and only oral…
Read More...

GSK and 23andMe unveiled an exclusive four-year collaboration that will focus on research and development of innovative new medicines and potential cures, using human genetics as the…
Read More...

Convelo Therapeutics, Inc. announced that it has launched from stealth mode with a mission to discover and develop a new class of medicines that regenerate the protective myelin coating…
Read More...

Koutif Therapeutics announced that KT-1002, which has been selected as its lead compound, has reached clinical candidate status for the treatment of inflammatory bowel disease,…
Read More...

Sanofi and REVOLUTION Medicines announced an exclusive worldwide partnership to develop and commercialize targeted therapies, based on the biology of the cellular enzyme SHP2, for…
Read More...

Roche announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for Tecentriq (atezolizumab) in combination with Avastin (bevacizumab) as…
Read More...

BioNTech AG and Genevant Sciences announced that they have entered into a collaboration to develop five mRNA therapeutic programs for rare diseases with high unmet medical need. The…
Read More...

SRI International announced a research agreement with Ionis Pharmaceuticals, combining SRI's proprietary FOX Three Molecular Guidance cellular targeting system (MGS) with Ionis'…
Read More...

Herantis Pharma Plc announced the initiation of a non-invasive CDNF development program to broaden the application of CDNF in Parkinson’s disease and potentially other neurodegenerative…
Read More...

Sorrento Therapeutics announced that it acquired the Sofusa lymphatic delivery technology platform from Kimberly-Clark Corporation for targeted biopharmaceuticals, particularly, the…
Read More...

Forendo Pharma, a drug development company focusing on novel oral treatments for endometriosis patients, announces that it has received clinical trial authorisation (CTA) from the UK's…
Read More...

Theratechnologies Inc. announced that it has filed a supplemental new drug application (sNDA) with the Food and Drug Administration (FDA) for a single-vial formulation of EGRIFTA.…
Read More...

Treating advanced breast cancer with three drugs instead of one could boost the effectiveness of treatment and stop tumours developing resistance, a new study reports. Researchers…
Read More...

RedHill Biopharma Ltd. announced that it has entered into a co-promotion agreement with Napo Pharmaceuticals, Inc. (Napo), a human health company developing and commercializing novel…
Read More...

AbbVie and Calibr announced a collaboration to develop T-cell therapies aimed primarily at cancer, including solid tumors. This collaboration broadens AbbVie's oncology research to…
Read More...

Roche announced that the U.S. Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) and granted Priority Review for baloxavir marboxil as a single-dose, oral…
Read More...